Cargando…
Recent trends in use of adjuvant chemotherapy in elderly stage II–III non-small cell lung cancer
BACKGROUND: Although randomized trials demonstrated survival benefit of adjuvant chemotherapy, previous reports have suggested that its use in elderly populations for early stage non-small cell lung cancer (NSCLC) was infrequent. The current status of adjuvant chemotherapy in this population is unkn...
Autores principales: | Komiya, Takefumi, Powell, Emily, Guddati, Achuta Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481576/ https://www.ncbi.nlm.nih.gov/pubmed/32953496 http://dx.doi.org/10.21037/tlcr-19-564 |
Ejemplares similares
-
Advances in the Treatment of Mucoepidermoid Carcinoma
por: Sama, Srikar, et al.
Publicado: (2022) -
Induction Immunotherapy Followed by Thoracic Radiation without Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: A Case Series
por: Dasari, Srikiran, et al.
Publicado: (2022) -
Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients
por: Chen, Xin, et al.
Publicado: (2022) -
Trends in the crossover of patients in phase III oncology clinical trials in the USA
por: Yeh, Justin, et al.
Publicado: (2020) -
Genetic Polymorphisms in Pharmaceuticals and Chemotherapy
por: Gummadi, Aneesha Choudary, et al.
Publicado: (2021)